ARNA Financial Facts

Interest expense: -1.76M
General and administrative: 8.07M
See Full Income Statement

Common stock: 22K
Prepaid expenses and other current assets: -6.8M
See Full Balance Sheet

Arena Pharmaceuticals, Inc. (ARNA) Earnings

  |   Expand Research on ARNA
Next EPS Date 5/5/14 *Est. EPS Growth Rate -10.0% *Last Qtr.
Average EPS % Beat Rate +8.8% Revenue Growth Rate +219.6% *Last Qtr.
Average % Move 1-Wk after EPS +6.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
3/4/13 Q412 -$0.10-$0.03 -$0.07$1.94M$21.94M N/A -25.9% Details
5/10/11 Q111 -$0.35-$0.21 -$0.14$3.92M$3.29M N/A +357.8% Details
8/9/12 Q212 -$0.12-$0.08 -$0.04$22M$7.38M N/A -16.6% Details
11/9/10 Q310 -$0.31-$0.23 -$0.08N/AN/A N/A +303.9% Details
5/2/13 Q113 $0.09$0.11 -$0.02N/A$50.36M N/A -26.4% Details
11/9/11 Q311 -$0.16-$0.14 -$0.02$3.46M$3.37M N/A +354.4% Details
3/11/11 Q410 -$0.23-$0.21 -$0.02$4.01M$4.81M N/A +306.6% Details
3/14/12 Q411 -$0.16-$0.15 -$0.01$2.08M$3.49M N/A +245.3% Details